Cited by 213Inhalation and Respiratory Drug DeliveryNanoparticle-Based Drug DeliveryRadiopharmaceutical Chemistry and Applications

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles

Videira, Mafalda A., Botelho, M.F., Santos, Ana C., Gouveia, Luis F., Pedroso de Lima, J.J., Almeida, António J.·2002·Journal of Drug Targeting

DOI 10.1080/1061186021000054933

Open this paper in CoChat — free account

Abstract

UNLABELLED: Lymphatic drainage plays an important role in the uptake of particulates in the respiratory system, being also associated to the spreading of lung cancer through metastasis development. In recent years solid lipid nanoparticles (SLN) have been proposed as carriers of anti-tumoural drugs, for their low toxicity and surface characteristics make them suitable for either imaging (gamma-scintigraphy) or therapy upon encapsulation of cytotoxic drugs. Assessment of inhaled radiolabelled SLN biodistribution is described in the present work. METHODS: Nanoparticles (200 nm) were radiolabelled with 99mTc using the lipophilic chelator D,L-hexamehylpropyleneamine oxime (HMPAO). Biodistribution studies were carried out following aerosolisation and administration of a 99mTc-HMPAO-SLN suspension to a group of adult male Wistar rats. A 60 min dynamic image acquisition was performed in a gamma-camera, followed by static image collection at 30 min intervals up to 4 h postinhalation. Radiation counting was performed in organ samples, collected after the animals were sacrificed. RESULTS: The data show an important and significant uptake of the radiolabelled SLN into the lymphatics after inhalation, and a high rate of distribution in periaortic, axillar and inguinal lymph nodes. CONCLUSION: Results indicate that SLN could be effective colloidal carriers for lymphoscintigraphy or therapy upon pulmonary delivery.

Integrity signals

Registry

Crossref · 10.1080/1061186021000054933

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,158
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,183
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Chen, X. Q., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647
The Role of Macrophages in Particle Translocation from Lungs to Lymph Nodes
Harmsen, A. G., Muggenburg, B. A., Snipes, M. B., & Bice, D. E. (1985) · Science · doi:10.1126/science.4071052 · Cited by 326
Lymphatic targeting with nanoparticulate system
Nishioka, Y., & Yoshino, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00121-6 · Cited by 221
Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148
Controlled delivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system.
Juliano, R. L., & McCullough, H. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32184-1 · Cited by 87
Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy.
Sharma, D., Chelvi, T. P., Kaur, J., Chakravorty, K., De, T., Maitra, A. N., & Ralhan, R. (1996) · PubMed · Cited by 85
The migration of bronchoalveolar macrophages into hilar lymph nodes.
Corry, D. B., Kulkarni, P. V., & Lipscomb, M. F. (1984) · PubMed · Cited by 79
Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats
Maincent, P., Thouvénot, P., Amicabile, C., Hoffman, M., Kreuter, J., Couvreur, P., & Devissaguet, J. P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015895804597 · Cited by 76

Show all 25 references

Sorted by citations

Items 101–200 of 210

Recent Updates on Applications of Lipid-Based Nanoparticles for Site- Specific Drug Delivery
Agrawal, S., Garg, A., & Varshney, V. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220304111848 · Cited by 32
Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor
Sharma, A. K., Sahoo, P. K., MAJUMDAR, D. K., Sharma, N., Sharma, R. K., & Kumar, A. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1183720 · Cited by 29
Inhaled rapamycin solid lipid nano particles for the treatment of Lymphangioleiomyomatosis
Landh, E., Moir, L. M., dos Reis, L. G., Traini, D., Young, P. M., & Ong, H. X. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105098 · Cited by 29
A REVIEW ON NANOTECHNOLOGY IN SOLID LIPID NANOPARTICLES
Sarathchandiran, I. (2012) · Cited by 28
Nanoparticle transport and delivery in a heterogeneous pulmonary vasculature
Sohrabi, S., Wang, S., Tan, J., Xu, J., Yang, J., & Liu, Y. (2016) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2016.11.023 · Cited by 28
Self-assembly PEGylation assists SLN-paclitaxel delivery inducing cancer cell apoptosis upon internalization
Arranja, A., Gouveia, L. F., Gener, P., Rafael, D. F. D. S., Pereira, C. A., Schwartz, S., & Videira, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.075 · Cited by 29
Self-citation
Solid Lipid Nanoparticles (SLN™)
Souto, E. B., Fangueiro, J. F., & Müller, R. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9164-4_5 · Cited by 27
Formulation technologies to overcome unfavorable properties of peptides and proteins for pulmonary delivery
Wan, F., Møller, E. H., Yang, M., & Jørgensen, L. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.12.003 · Cited by 27
Imaging drug delivery to the lungs: Methods and applications in oncology
Man, F., Tang, J., Swedrowska, M., Forbes, B., & de Rosales, R. T. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114641 · Cited by 27
Sentinel lymph node identification using NIR-II ultrabright Raman nanotags on preclinical models
Deng, B., Wang, Y., Bu, X., Li, J., Lu, J., Lin, L. L., Wang, Y., Chen, Y., & Ye, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122538 · Cited by 26
Inhalable nanomedicine for lung cancer treatment
Zhang, S., Li, R., Jiang, T., Gao, Y., Zhong, K., Cheng, H. B., Chen, X., & Li, S. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2024.04.001 · Cited by 26
Distribution of Effervescent Inhalable Nanoparticles After Pulmonary Delivery: an In Vivo Study
Alhallak, K., Sarfraz, M., Azarmi, S., Roa, W., Finlay, W. H., Rouleau, C., & Löbenberg, R. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.42 · Cited by 26
Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles
Pedata, P., Petrarca, C., Garzillo, E. M., & Gioacchino, M. D. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015608933 · Cited by 26
How to detect a dwarf: in vivo imaging of nanoparticles in the lung
Roller, J., Laschke, M. W., Tschernig, T., Schramm, R., Veith, N. T., Thorlacius, H., & Menger, M. D. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.02.010 · Cited by 25
Harnessing Biomaterials and the Lymphatic System for ImmunomodulationPreprint
Alderfer, L., Hall, E., & Hanjaya‐Putra, D. (2020) · SSRN Electronic Journal · doi:10.1016/j.actbio.2021.06.006 · Cited by 26
Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND)
Abbate, M. T. A., Ramöller, I. K., Sabri, A. H. B., Paredes, A. J., Hutton, A. R. J., McKenna, P. E., Peng, K., Hollett, J. A., McCarthy, H. O., & Donnelly, R. F. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123005 · Cited by 25
Silibinin loaded inhalable solid lipid nanoparticles for lung targeting
Patel, P. V., Raval, M. K., Airao, V., Bhatt, V. D., & Shah, P. (2021) · Journal of Microencapsulation · doi:10.1080/02652048.2021.2002448 · Cited by 24
Multimodal pulmonary clearance kinetics of carbon black nanoparticles deposited in the lungs of rats: the role of alveolar macrophages
Lee, D.-K., Kim, G., Maruthupandy, M., Lee, K., & Cho, W. (2024) · Particle and Fibre Toxicology · doi:10.1186/s12989-024-00591-9 · Cited by 25
Physiologically Based Pharmacokinetic Modeling for Nanoparticle Toxicity Study
Li, M., & Reineke, J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-002-1_24 · Cited by 22
Nanomedicine-Based Inhalation Treatments for Lung Cancer
Rosière, R., Amighi, K., & Wauthoz, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815720-6.00010-1 · Cited by 22
Methods for Radiolabelling Nanoparticles: SPECT Use (Part 1)
Varani, M., Bentivoglio, V., Lauri, C., Ranieri, D., & Signore, A. (2022) · Biomolecules · doi:10.3390/biom12101522 · Cited by 23
Nanomaterials for Enhanced Immunity as an Innovative Paradigm in Nanomedicine
Seth, A., Oh, D., & Lim, Y. T. (2015) · Nanomedicine · doi:10.2217/nnm.14.200 · Cited by 21
Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administration
Patel, A., Woods, A., Riffo‐Vasquez, Y., Morgan, A. B., Jones, M., Jones, S. A., Sunassee, K., Clark, S. K., de Rosales, R. T. M., Page, C. P., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.024 · Cited by 20
Nanomedicine in pulmonary delivery
Das, S. C., Khadka, P., Shah, R., McGill, S. L., & Smyth, H. D. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820466-5.00014-4 · Cited by 20
Lipid‐Based Nanocarriers as Drug Delivery System and Its Applications
Jain, V. K., Kumar, H., Chand, P., Jain, S., & P, P. S. (2021) · doi:10.1002/9781119711698.ch1 · Cited by 20
Experimental design towards an optimal lipid nanosystem: A new opportunity for paclitaxel-based therapeutics
Videira, M., Arranja, A., & Gouveia, L. F. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.03.005 · Cited by 19
Self-citation
Differential Interactions of Gelatin Nanoparticles with the Major Lipids of Model Lung Surfactant: Changes in the Lateral Membrane Organization
Daear, W., Lai, P. K., Anikovskiy, M., & Prenner, E. J. (2015) · The Journal of Physical Chemistry B · doi:10.1021/jp5122239 · Cited by 19
Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives
Cai, Z., Li, Z., Zhong, N., Cao, L., Xiao, Y., Li, J., Huo, F., Liu, B., Xu, C., Zhao, Y. F., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02408-5 · Cited by 18
Delivery Systems for Lymphatic Targeting
Singh, I., Swami, R., Khan, W., & Sistla, R. (2013) · Advances in delivery science and technology · doi:10.1007/978-1-4614-9434-8_20 · Cited by 18
Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model
Sancini, G., Magro, R. D., Ornaghi, F., Balducci, C., Forloni, G., Gobbi, M., Salmona, M., & Re, F. (2016) · Nano Research · doi:10.1007/s12274-016-1108-8 · Cited by 18
Are Inhaled Systemic Therapies a Viable Option for the Treatment of the Elderly Patient?
Allen, S. (2008) · Drugs & Aging · doi:10.2165/00002512-200825020-00001 · Cited by 18
Pulmonary Administration: Strengthening the Value of Therapeutic Proximity
Videira, M., Llop, J., Sousa, C., Kreutzer, B., Cossío, U., Forbes, B., Vieira, I., Gil, N., & Lima, B. S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00050 · Cited by 18
Self-citation
Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery
Singh, A., Malviya, R., & Sharma, P. K. (2011) · Current Drug Therapy · doi:10.2174/157488511795304930 · Cited by 16
Nanostructured Lipid Carriers and their application in drug delivery
Khurana, S., Utreja, P., Tiwary, A. K., Jain, N. K., & Jain, S. K. (2009) · International Journal of Biomedical Engineering and Technology · doi:10.1504/ijbet.2009.022913 · Cited by 16
Evaluation of biocompatible stabilised gelled soya bean oil nanoparticles as new hydrophobic reservoirs
Boudier, A., Kirilov, P., Franceschi, S., Belkhelfa, H., Haddioui, L., Roques, C. G., Pérez, E., & Rico‐Lattes, I. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.506582 · Cited by 14
Alternatives to conventional suspensions for pulmonary drug delivery by nebulisers: A review
Amani, A., Amini, M. A., Ali, H. S. M., & York, P. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22665 · Cited by 14
Properties of Rapamycin Solid Lipid Nanoparticles for Lymphatic Access Through The Lungs & Part II: The Effect of Nanoparticle Charge
Landh, E., Moir, L. M., Traini, D., Young, P. M., & Ong, H. X. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0192 · Cited by 14
Critical Analysis of Cancer Therapy using Nanomaterials
Juillerat‐Jeanneret, L. (2003) · Nanotechnologies for the Life Sciences · doi:10.1002/9783527610419.ntls0066 · Cited by 14
Recent Updates in Inhalable Drug Delivery System against Various Pulmonary Diseases: Challenges and Future Perspectives
Chaudhary, K. R., Singh, K., & Singh, C. (2023) · Current Drug Delivery · doi:10.2174/0115672018265571231011093546 · Cited by 14
Metal Nanoparticle Health Risk Assessment
Gioacchino, M. D., Verna, N., Gornati, R., Sabbioni, E., & Bernardini, G. (2009) · Wiley eBooks · doi:10.1002/9780470747803.ch24 · Cited by 13
Cytotoxicity and Cellular Internalization Studies of Biogenic Gold Nanotriangles in Animal Cell Lines
Singh, A., Shukla, R., Hassan, S., Bhonde, R. R., & Sastry, M. (2011) · International Journal of Green Nanotechnology · doi:10.1080/19430892.2011.633479 · Cited by 12
Improving Nutrition Through the Design of Food Matrices
Rommy, N. Z., & Troncoso, E. (2012) · InTech eBooks · doi:10.5772/33504 · Cited by 13
La chimiothérapie inhalée – partie 1 : concept et challenges technologiques actuels
Rosière, R., Hureaux, J., Levet, V., Amighi, K., & Wauthoz, N. (2018) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2018.02.001 · Cited by 12
Drug Delivery to the Lymphatic System
Yang, Q., & Forrest, L. M. (2016) · Drug Delivery · doi:10.1002/9781118833322.ch21 · Cited by 12
Technosphere®: An Inhalation System for Pulmonary Delivery of Biopharmaceuticals
Almeida, A. J., & Grenha, A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9524-6_22 · Cited by 10
Self-citation
Preparation and evaluation of effect on Escherichia coli and Staphylococcus aureus of radiolabeled ampicillin‐loaded graphene oxide nanoflakes
Yurt, F., Ersöz, O. A., Harputlu, E., & Ocakoğlu, K. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13171 · Cited by 9
Deep pulmonary lymphatics in immature lungs
Dickie, R., Cormack, M., Semmler‐Behnke, M., Kreyling, W. G., & Tsuda, A. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90665.2008 · Cited by 9
Nanostructure Drug Delivery System Is an Option to Solve Antimicrobial Drug Resistance
Patil, J., Dhadde, S. B., & Chandakavathe, B. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814031-4.00007-6 · Cited by 9
Science and Technology of Pressurized Metered-Dose Inhalers
da Rocha, S. R. P., Bharatwaj, B., & Saiprasad, S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9745-6_8 · Cited by 10
Imaging the paediatric lung: what does nanotechnology have to offer?
Ordidge, K., Duffy, B. A., Wells, J. A., Kalber, T. L., Janes, S. M., & Lythgoe, M. F. (2011) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2011.07.001 · Cited by 8
Nanostructures for Overcoming the Pulmonary Barrier: Drug Delivery Strategies
Colombo, P. C., Sonvico, F., & Buttini, F. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735292-00273 · Cited by 8
Nanoparticles in Drug Delivery Systems
Castro, E., & Kumar, A. (2013) · CRC Press eBooks · doi:10.1201/b14802-4 · Cited by 8
Nanotechnology and pharmaceutical inhalation aerosols.
Patel, A. R., & Vavia, P. R. (2007) · PubMed · Cited by 8
Nanoparticles: Scope in Drug Delivery
Tanwar, M., Meena, J., & Meena, L. S. (2014) · Wiley eBooks · doi:10.1002/9781118774052.ch14 · Cited by 8
Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy
Cho, K. J., Cho, Y., & Kim, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122752 · Cited by 7
Development of Adjuvanted Solid Fat Nanoemulsions for Pulmonary Hepatitis B Vaccination
Minz, S., & Pandey, R. S. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.02.007 · Cited by 7
Properties of Rapamycin Solid Lipid Nanoparticles for Lymphatic Access Through The Lungs & Part I: The Effect of Size
Landh, E., Moir, L. M., Bradbury, P., Traini, D., Young, P. M., & Ong, H. X. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0077 · Cited by 7
Solid Lipid Nanoparticles - SLN
Musicanti, C., & Gasco, P. (2012) · Springer eBooks · doi:10.1007/978-90-481-9751-4_249 · Cited by 7
Liposomes are Poorly Absorbed via Lung Lymph After Inhaled Administration in Sheep
Ibrahim, J., Haque, S., Bischof, R. J., Whittaker, A. K., Whittaker, M. R., & Kaminskas, L. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.880448 · Cited by 6
Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics
Ekinci, M., Magne, T. M., Alencar, L. M. R., Fechine, P. B. A., Santos‐Oliveira, R., & İlem‐Özdemir, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030404 · Cited by 6
A Review on Aerosol Drug Delivery: Fundamentals, Classifications, Particle Size Analysis and the Engagement of Nanoparticulate Systems
Mneimneh, A. T., & Elmaradny, H. A. (2022) · Drug Delivery Letters · doi:10.2174/2210303112666220831100748 · Cited by 6
Bioinspired nanoparticles-based drug delivery systems for cancer theranostics
Madamsetty, V. S., Mukherjee, A., & Paul, M. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821467-1.00008-2 · Cited by 6
Research for a new imaging agent: In vivo examination of silymarin loaded solid lipid nanoparticles radiolabeled with 99mTc in rabbits
Eroğlu, H., Ayan, A. K., & Yenilmez, A. (2024) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2024.112328 · Cited by 5
Solid lipid nanoparticles; as a promising drug delivery method to get greater bioavailability: A review
Lavate, M. A., Karpe, S. T., Biradar, S. N., & Bhandare, M. R. (2023) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2023.14.2.0104 · Cited by 5
Introduction
Shah, R., Eldridge, D. S., Palombo, E. A., & Harding, I. H. (2014) · SpringerBriefs in pharmaceutical science & drug development · doi:10.1007/978-3-319-10711-0_1 · Cited by 5
Antitumor Effect of Bleomycin Nanoaerosol in Murine Carcinoma Model
Karshieva, S. S., Babayeva, G. A., Pokrovsky, V. S., Shlyapnikov, Y. M., Shlyapnikova, E. A., Bugrova, A. E., Kononikhin, A. S., Николаев, Е. Н., & Kanev, I. L. (2023) · Molecules · doi:10.3390/molecules28104157 · Cited by 5
Considerations for the Design of Toxicity Studies of Inhaled Nanomedicines
Dailey, L. A. (2009) · doi:10.1002/9780470747803.ch3 · Cited by 5
Is particle size reduction linked to drug efficacy: an overview into nano initiatives in pharmaceuticals
Sher, M., Zahoor, M., Shah, S. W. A., & Khan, F. A. (2023) · Zeitschrift für Physikalische Chemie · doi:10.1515/zpch-2023-0221 · Cited by 4
Nanoparticles for Radionuclide Imaging and Therapy: Principles
Kennel, S., Appavoo, A., Schulz, J., & Barthélémy, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_22 · Cited by 4
Role of Lipid Nanocarriers in Lymphatic Targeting: Promises and Safety Considerations
Desai, J. L., & Thakkar, H. P. (2021) · Springer eBooks · doi:10.1007/978-981-33-4497-6_2 · Cited by 4
Host-directed strategies using lipid nanoparticles to reduce mycobacteria survival
Pereira, L. P., Diogo, J., Mateus, R., Pimentel, M., & Videira, M. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-2892-x · Cited by 4
Self-citation
Lipidic Micro‐ and Nano‐Carriers for Pulmonary Drug Delivery—A State‐of‐the‐Art Review
Rahimpour, Y., Hamishehkar, H., & Nokhodchi, A. (2015) · doi:10.1002/9781118799536.ch6 · Cited by 4
Nanomedicines in Tuberculosis: Diagnosis, Therapy and Nanodrug Delivery
Dakkah, A. N., Bataineh, Y. A., Al-Jaidi, B. A., Bayan, M. F., & Nimer, N. A. (2020) · Engineering materials · doi:10.1007/978-3-030-36260-7_13 · Cited by 3
In vivo safety and particokinetics of inhaled nanomedicines
Jones, M., Kumar, A., Spina, D., Forbes, B., Page, C. P., & Dailey, L. A. (2011) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(11)50052-8 · Cited by 3
Metal Nanoparticle Health Risk Assessment
Giampaolo, L. D., Petrarca, C., Mangifesta, R., Schiavone, C., Pini, C., Malandra, A., Bramante, F., Pollutri, A., Frischia, M. D., & Gioacchino, M. D. (2020) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-15-4735-5_2 · Cited by 3
A concise review on nanoscale carriers to target intracellular infections
Maithania, H. V., & Gundeti, M. (2026) · Discover Pharmaceutical Sciences · doi:10.1007/s44395-026-00038-4 · Cited by 2
Theranostics Nanomaterials for Safe Cancer Treatment
Pillai, S. C., Anirudhan, A., & Kumar, D. S. (2023) · Springer eBooks · doi:10.1007/978-981-19-7834-0_5 · Cited by 2
Nanomedicines: Nano based Drug Delivery Systems Challenges and Future of nanomedicines
Navnath, N. S., & Sahebrao, N. U. (2024) · Asian Journal of Pharmacy and Technology · doi:10.52711/2231-5713.2024.00024 · Cited by 2
Improvement in the bioavailability of poorly water-soluble drugs via pulmonary delivery of nanoparticles
Yang, W. P. (2009) · Texas ScholarWorks (Texas Digital Library) · Cited by 2
Radioiodination and biodistribution of NBNPQD (2-benzyl-1-oxo-1,2-dihydropyrido[4,3-b]quinoxaline 5,10-dioxide) in tumor bearing mice
Ibrahim, I. T., Habib, S. A., Wally, H. A., & El‐Shishtawy, M. M. (2012) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-012-2282-0 · Cited by 2
Nanopharmaceuticals
Yurdasiper, A., Arıcı, M., & Özyazıcı, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40016-9.00007-5 · Cited by 2
Emerging Nanotechnology Approaches for Pulmonary Delivery of Vaccines
Goyal, A. K., Rath, G., & Malik, B. (2013) · Springer eBooks · doi:10.1007/978-3-319-00978-0_11 · Cited by 2
Colloidal gold nanoparticles for cancer therapy: effects of particle size on treatment efficacy, toxicology, and biodistribution
Lee, K. Y. J. (2011) · SMARTech Repository (Georgia Institute of Technology) · Cited by 2
Theranostics Nanomedicine: Recent Advancement, Applications and Challenges
Ghaywat, S. D., Payal, D., Gaurkar, S., Upadhyay, S., Raut, V., Binjhade, N., Wadher, K., & Umekar, M. J. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i60b34927 · Cited by 1
Quantitative, Qualitative and In Vitro Evaluation of Solid Lipid Nanoparticles Containing 5-Fluorouracil
Majrad, M. S. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
94-OR: Lipid Nanoparticle-Mediated Delivery of Enhanced Costimulation Blockade to Prevent Type 1 Diabetes
Zhang, Y., Wang, J., Calderón‐Colón, X., Tiburzi, O. N., LOZANO, M. I., Patrone, J. B., & Raimondi, G. (2019) · Diabetes · doi:10.2337/db19-94-or · Cited by 1
Prospective nanoparticle treatments for lymphangioleiomyomatosis
Landh, E., Wang, R., Moir, L. M., Traini, D., Young, P. M., & Ong, H. X. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2029401 · Cited by 1
Nanotechnology to Improve Oral Drug Delivery
Bhavsar, M. D., Jain, S., & Amiji, M. M. (2008) · Wiley eBooks · doi:10.1002/9780470431818.ch10 · Cited by 1
Lipid Nanoparticle‐Based Systems for Delivery of Biomacromolecule Therapeutics
Martins, S., Ferreira, D., & Souto, E. B. (2009) · doi:10.1002/9780470688397.ch7 · Cited by 1
Nanoparticle Agglomeration via Ionic Colloidal Destabilization as a Novel Approach to Dry Powder Formulations for Pulmonary Drug Delivery
Plumley, C. J. (2008) · KU ScholarWorks (University of Kansas) · Cited by 1
Microencapsulación de nanopartículas de quitosano para la administración pulmonar de macromoléculas terapéuticas
Grenha, A. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Solid Lipid Nanoparticles (SLN)
Musicanti, C., & Gasco, P. (2016) · Springer eBooks · doi:10.1007/978-94-017-9780-1_249 · Cited by 1
VAGINAL DELIVERY OF A HYDROPHOBIC ANTIRETROVIRAL DRUG CSIC FOR HIV PREVENTION: NOVEL FORMULATION STRATEGIES FOR IMPROVED DRUG SOLUBILIZATION AND LYMPHATIC TARGETING
Gong, T. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Combination of Solvent Displacement and Wet Ball Milling Techniques for Size Reduction of Celecoxib
Yaqoubi, S., Barzegar-Jalali, M., Adibkia, K., & Hamishehkar, H. (2016) · Pharmaceutical Sciences · doi:10.15171/ps.2016.05
Literature Watch
Pepper, M. S. (2003) · Lymphatic Research and Biology · doi:10.1089/153968503768330274
Use of Systems Biology in Deciphering Mode of Action and Predicting Potentially Adverse Health Outcomes of Nanoparticle Exposure, Using Carbon Black as a Model
Bourdon, J. A. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-5282
In vitro digestibility of food-grade emulsions
Ahués, E. T. (2014) · doi:10.7764/tesisuc/ing/2931
SOLID LIPID NANOPARTICLES: A NOVEL POTENTIAL CARRIER APPROACH
Rewar, S., Mirdha, D., & Rewar, P. (2014)
Chapter 4: Emerging Nanopharmaceuticals
Yim, E. K. F., & Leong, K. W. (2017) · CRC Press eBooks · doi:10.1201/9781315114361-5
Mini-Symposium: Nanoparticles and Children's Lungs Imaging the paediatric lung: what does nanotechnology have to offer?
Ordidge, K., Duffy, B., Wells, J. A., Kalber, T. L., Janes, S. M., & Lythgoe, M. F. (2012)

Authors: Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J.
Affiliations: University of Lisbon (PT)
University of Coimbra (PT)
ORCID: Videira, Mafalda A.
Botelho, M.F.
Santos, Ana C.
Almeida, António J.
Venue: Journal of Drug Targeting
Publisher: Informa UK Limited
Published: 2002-01
Volume: 10
Issue: 8
Pages: 607-613
ISSN: 1026-7158 (ISSN-L)
1061-186X
1029-2330
DOI: 10.1080/1061186021000054933
OpenAlex: W2115533786
Cited by: 213
References: 25
Citations by year: 2026: 1 · 2025: 1 · 2024: 9 · 2023: 8 · 2022: 10 · 2021: 14 · 2020: 10 · 2019: 7 · 2018: 11 · 2017: 8 · 2016: 14 · 2015: 12 · 2014: 12 · 2013: 14 · 2012: 14
FWCI: 1.64
Type: journal article
Language: en
Open access: closed
Locations: Journal of drug targeting (publishedVersion)
PubMed (publishedVersion)
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
Funders: Fundação para a Ciência e a Tecnologia
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Keywords: solid lipid nanoparticles, lymphatic absorption, pulmonary drug delivery, aerosol inhalation, 99mTc-HMPAO, tissue distribution, lymphoscintigraphy, lymph node distribution, lung cancer metastasis, scintigraphy, nanoparticle drug carriers
MeSH terms: Administration, Inhalation, Animals, Colloids, Drug Carriers, Image Processing, Computer-Assisted, Isotope Labeling, Lipids, Lung, Lymphatic System, Male, Microspheres, Spirometry, Tissue Distribution, Rats, Wistar, Radiopharmaceuticals, Technetium Tc 99m Exametazime, Rats, Lymphoscintigraphy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks